401 related articles for article (PubMed ID: 7419959)
1. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man.
Regan PT; Go VL; DiMagno EP
J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959
[TBL] [Abstract][Full Text] [Related]
2. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans.
You CH; Rominger JM; Chey WY
Gastroenterology; 1983 Jul; 85(1):40-5. PubMed ID: 6303892
[TBL] [Abstract][Full Text] [Related]
3. Interaction of neurotensin, secretin and cholecystokinin on pancreatic exocrine secretion in conscious dogs.
Sakamoto T; Fujimura M; Townsend CM; Greeley GH; Thompson JC
Surg Gynecol Obstet; 1988 Jan; 166(1):11-6. PubMed ID: 3336811
[TBL] [Abstract][Full Text] [Related]
4. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans.
Thimister PW; Hopman WP; Tangerman A; Rosenbusch G; Willems HL; Jansen JB
Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206
[TBL] [Abstract][Full Text] [Related]
5. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of the pancreatic secretion of immunoreactive carcinoembryonic antigen, enzyme, and bicarbonate in patients suspected of having pancreatic cancer.
DiMagno EP; Malagelada JR; Moertel CG; Go VL
Gastroenterology; 1977 Sep; 73(3):457-61. PubMed ID: 892342
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the synthetic cholecystokinin analogues caerulein and Thr28NlE31CCK25-33(CCK9) with regards to plasma bioactivity, degradation rate and stimulation of pancreatic exocrine function.
Mössner J; Sprenger C; Secknus R; Kestel W; Fischbach W
Z Gastroenterol; 1991 Feb; 29(2):59-64. PubMed ID: 1714671
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic, gallbladder, and gastric responses to intraduodenal calcium perfusion in man.
Holtermuller KH; Mallagelada JR; McCall JT; Go VL
Gastroenterology; 1976 May; 70(5 PT.1):693-6. PubMed ID: 1261760
[TBL] [Abstract][Full Text] [Related]
9. Mediators of exocrine pancreatic secretion induced by intraduodenal application of bile and taurodeoxycholate in man.
Riepl RL; Reichardt B; Rauscher J; Tzavella K; Teufel J; Lehnert P
Eur J Med Res; 1997 Jan; 2(1):23-9. PubMed ID: 9049590
[TBL] [Abstract][Full Text] [Related]
10. Exocrine pancreatic secretion and plasma levels of cholecystokinin, pancreatic polypeptide, and somatostatin after single and combined intraduodenal application of different bile salts in man.
Riepl RL; Fiedler F; Kowalski C; Teufel J; Lehnert P
Ital J Gastroenterol; 1996; 28(8):421-9. PubMed ID: 9032583
[TBL] [Abstract][Full Text] [Related]
11. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of the pancreatic and biliary response to CCK and secretin. Primate biliary physiology. XIII.
Gardner BN; Small DM
Gastroenterology; 1976 Mar; 70(3):403-7. PubMed ID: 814029
[TBL] [Abstract][Full Text] [Related]
13. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
Otto B; Mawe GM; Riepl RL
Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
[TBL] [Abstract][Full Text] [Related]
14. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
Chey WY; Lee KY; Chang TM; Chen YF; Millikan L
Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels.
Beglinger C; Fried M; Whitehouse I; Jansen JB; Lamers CB; Gyr K
J Clin Invest; 1985 May; 75(5):1471-6. PubMed ID: 3998145
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
[TBL] [Abstract][Full Text] [Related]
17. Differing sensitivities of gallbladder and pancreas to cholecystokinin-pancreozymin (CCK-PZ) in man.
Malagelada JR; Go VL; Summerskill WH
Gastroenterology; 1973 May; 64(5):950-4. PubMed ID: 4700421
[No Abstract] [Full Text] [Related]
18. Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function.
Malagelada JR; Go VL; DiMagno EP; Summerskill WH
J Clin Invest; 1973 Sep; 52(9):2160-5. PubMed ID: 4727454
[TBL] [Abstract][Full Text] [Related]
19. Effect of intraduodenal taurodeoxycholate and L-phenylalanine on pancreatic secretion and on gastroenteropancreatic peptide release in man.
Riepl RL; Fiedler F; Ernstberger M; Teufel J; Lehnert P
Eur J Med Res; 1996 Sep; 1(11):499-505. PubMed ID: 9438149
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of gastric emptying is a physiological action of cholecystokinin.
Debas HT; Farooq O; Grossman MI
Gastroenterology; 1975 May; 68(5 Pt 1):1211-7. PubMed ID: 1126597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
